During his tenure at Inovalon, Dr. Dunleavy has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insight and improvement for its constituents. Driven by a desire to help empower a data-driven transformation of healthcare, Dr. Dunleavy has led Inovalon from its origins to its current industry-leading position leveraging advanced, cloud-based platforms that are informed by data pertaining to more than one million physicians, 594,000 clinical facilities, 348 million unique patients, and 68 billion medical events empowering meaningful improvements in clinical outcomes and economics across the entire healthcare ecosystem.
Dr. Dunleavy received a bachelor’s degree in biology modified with engineering with high honors from Dartmouth College where his studies and work focused upon the neurosciences, computer sciences, and electrical engineering with his honors thesis focused on the computer simulation of artificial human cerebellar functional units. Dr. Dunleavy earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, practiced, and was Board Certified in Internal Medicine. He has authored or co-authored a number of scientific journal articles, abstracts, and proprietary research papers, has presented his work and materials at multiple national and international conferences, and has been awarded multiple U.S. patents pertaining to the real-time aggregation, analysis, and application of healthcare data.
Prior to joining Inovalon, Mr. Kelly was an executive at Amazon where he served as the General Manager of World-Wide Product Marketing for Amazon Web Services (AWS) for more than 40 services across six major categories representing over $35B in AWS revenue, including Compute, Storage, Hybrid Cloud, Networking and Global Infrastructure, Business Applications, and End User Computing. While at Amazon, Mr. Kelly led the product launch of more than 50 AWS services, including Amazon’s Outposts, Wavelength, Amazon Connect, Transit Gateway, and major capabilities in S3 and EC2 instances with Graviton processors. Prior to Joining Amazon in 2017, Mr. Kelly served as the General Manager and World-Wide Sales Leader at Microsoft for their cloud-based Office 365 suite where he was responsible for the go-to-market strategy, sales execution, and global growth results, successfully increasing enterprise sales from $3 billion to $7 billion over a three-year period. Prior to the General Manager and World-Wide Sale Leader role at Microsoft, Mr. Kelly served as General Manager and other roles for numerous Microsoft product offerings, including SQL Server, Microsoft’s big data platform, Windows Azure, Office 365, Unified Communications Services, and E-Business Servers. Within these roles, Mr. Kelly held responsibilities ranging from product management, sales, marketing, partner enablement, and helping customers transition from server software to cloud services, amongst others.
Prior to joining Microsoft in 2000, Mr. Kelly served as an officer in the United States Air Force as a Program Manager, Materials Directorate, at the Air Force Research laboratory in Dayton, Ohio. He graduated cum laude with a Bachelor of Science in Electrical Engineering from Princeton University, and received a Masters in Business Administration from Harvard Business School with first year honors.
Prior to joining Inovalon in 2016, Ms. Allen was the Chief Integrity Officer at MedStar Washington Hospital Center in Washington, D.C., a nationally recognized healthcare provider. In that capacity, she directed and led the enterprise-wide compliance, privacy, investigative and audit functions. Ms. Allen’s previous experience also includes various leadership roles with Booz Allen Hamilton and SRA International where she was responsible for developing, leading and overseeing legal, compliance, risk management, privacy and information security solutions across the federal and commercial sectors and assessing the privacy and security impact and risks associated with new and emerging products and technologies. In addition, Ms. Allen served as a Senior Attorney Advisor for the U.S. Department of Education, District of Columbia Enforcement Office, where she led numerous legal and compliance initiatives and a variety of complex and high-profile investigations. Ms. Allen also was a Senior Advisor for the Department of Homeland Security where she conceptualized and directed initiatives designed to implement various compliance mandates across the department and its component organizations.
Ms. Allen serves on the board of directors of Intapp (a provider of cloud-based software for the professional and financial services industries). She also serves on the boards of My Sister’s Place and the Appleseed Network. Additionally, Ms. Allen is also a member of the District of Columbia Bar, Legal Ethics Committee and a Vice-Chair of the Association of Corporate Counsel, Health Law Network.
Ms. Allen received her Bachelor of Arts from the University of Virginia, Juris Doctor from the University of North Carolina and a Master of Arts from Georgetown University.
Prior to joining the Company in 2012, Mr. Boldt served in a number of escalating roles at Deloitte & Touche, LLP, ultimately holding the position of attestation manager for public and private, domestic and international clients in information technology, government contracting, professional services, and manufacturing industries at various growth stages and scale ranging from $200 million to $20 billion in annual revenue.
Mr. Boldt graduated magna cum laude from Loyola University in Maryland with a bachelor degree in accounting and a masters of business administration degree with an information technologies concentration. He serves on the Loyola University of Maryland Sellinger School of Business Joint Advisory Board.
Mr. Boldt is an active certified public accountant in the State of Maryland, a status which he has held since 2008.
Prior to joining Inovalon in 2017, Mr. Brow served as Senior Vice President of Operations for the US Oncology Network at McKesson Specialty Health, and Vice President and General Manager of Vantage Oncology southeast region. Previously, Mr. Brow held roles at McKesson and its predecessor company, US Oncology, where he led public policy; mergers and acquisitions; business development; go-to-market strategy; sales; reimbursement strategy; federal and state government relations; and communications. Prior to joining US Oncology, he served as a consultant, advising clients on state government affairs strategy across a wide-range of healthcare and political issues.
Mr. Brow has published in peer-reviewed and professional journals on healthcare policy, the Affordable Care Act, cancer care quality, and value-based care. He holds a BA in history and political science from the University of Richmond.
Prior to joining Inovalon in 2010, Mrs. Keeneth served in several strategic roles at management consulting firms, DRT Strategies and BearingPoint, supporting clients in federal, regulatory, and real estate industries. This experience includes extensive knowledge and application of information security and compliance, security governance, policy, and risk management within the federal government and private sectors.
Mrs. Keeneth holds a master’s degree from the University of Virginia in Management of Information Technology and a bachelor’s degree from George Mason University in Finance.
Prior to joining Inovalon in 2007, Dr. Kilian was in clinical practice with Johns Hopkins Community Physicians, where she served as Medical Director with responsibilities including patient care, clinical training of medical students and residents, and clinical oversight of a multispecialty practice.
Dr. Kilian graduated summa cum laude from Washington and Lee University and earned her doctorate in medicine from Tufts University School of Medicine. She completed her residency in Internal Medicine at The Johns Hopkins Hospital in Baltimore, Maryland.
Prior to her time at Inovalon, Ms. Lambert was the Vice President, Specialty Pharmacy at OptumRx, a division of UnitedHealth Group. In this capacity, she led the operations of a $16.5 billion business that spanned multiple regions across the United States while managing a team of over 1,200 people to achieve the business’s clinical, operational, and financial goals. While at UnitedHealth Group, Ms. Lambert also led roles driving mergers and acquisitions, large scale integrations, developing business strategy, and creating supporting businesses cases to identify new growth opportunities. Prior to her time at UnitedHealth Group, Ms. Lambert held various roles at Prime Therapeutics, including product management, clinical operations, business development, quality improvement, and membership operations.
Ms. Lambert holds a Bachelor of Science in Business Administration from University of Wisconsin-La Crosse and holds numerous certifications.
Prior to her time at Inovalon, Ms. Olsen was the Chief Integration and People Office for OnRobot, and prior to that she spent 20 years at Dell EMC, a global technology leader, where she served as Vice President of Strategy and Go-To-Market for the EMEA Enterprise at Dell EMC. In this role, Ms. Olsen was responsible for the integration activities and go-to-market strategy of Dell EMC across the EMEA Enterprise segment, a $4 billion business covering 1,400 enterprise accounts across 38 countries. Her other roles at Dell EMC demonstrate her experience in running impactful operational teams that drive high performance including developing new go to market models, driving go to market execution, driving the integration activities for global corporate mergers, and defining Dell EMCs international strategy in EMEA. Prior to her time at EMC, Ms. Olsen worked for the law firm of Skadden Arps in Boston, Massachusetts, supporting its global corporate mergers and acquisitions practice.
Ms. Olsen graduated with a Bachelors of Arts Degree, Summa Cum Laude, in Political Science and Psychology from Northeastern University in Boston, Massachusetts.
Prior to joining Inovalon, Mr. Savage was a senior executive at Optum, Inc., a division of UnitedHealth Group, reporting to the Optum Insight CEO, where he served as Senior Vice President responsible for the global payer consulting organization. In this role, Mr. Savage oversaw a team of more than 1,000 personnel serving an extensive portfolio of health plan customers across six areas of Risk Management & Growth, Government Programs, Health Management & Operations, Payer Technology, Professional Staffing, and Payer Digital. Prior to his role at Optum, Mr. Savage served as Partner and Managing Director for the Health & Public Sector for Accenture, LLP where he directed the practice focused on payers and providers across Accenture’s key pillars of Enterprise Operations, Clinical Excellence, Growth and Innovation, Analytics, and Digital Health. Prior to joining Accenture in 2013, Mr. Savage had served in senior rolls at PWC Strategy& as Principal and Director of Global Healthcare, STS Capital Partners, Videre, Inc., and McKinsey & Company.
Mr. Savage graduated with a Bachelor of Science in Computer Science from the University of Maryland and has undertaken multiple postgraduate executive development programs at the University of Pennsylvania’s Wharton School of Business, Harvard Business School, and Southern Methodist University.
Mr. Creehan previously served as president and general manager of Inovalon’s pharmacy software business where he led the Company’s design, development, advancement, and support of data-driven pharmacy solutions.
Mr. Creehan has a 25 year history of pharmacy technology solution development and implementation and is the founder of Creehan and company, the industry’s leading provider of enterprise software for the pharmacy marketplace. After combining Creehan and company with Inovalon in 2016, Mr. Creehan has led the strategy and innovation of the Company’s next generation pharmacy platform solution. Leveraging a modular cloud-based architecture, and the data, connectivity, and analytical capabilities of the Inovalon ONE® Platform, ScriptMed® Cloud is the industry’s most advanced enterprise pharmacy platform.
Mr. Creehan has a proven track record for driving business growth from start-up pharmacies to several Fortune 500 clients through technology and innovation, and is an established industry thought leader. He has played an active role in advancing technology and automation for clinical decision support, care coordination, pharmacy practice, and pharmaceutical distribution. Providing the strategy, vision, and architecture for the company’s technologies, Mr. Creehan has lead the company to the number one market position in specialty pharmacy, and establishment of leading technology for driving clinical quality and patient outcomes in pharmacy.
Mr. Creehan holds a B.S. in Information Systems from Robert Morris University and is a graduate of the Entrepreneurial Management Program at Carnegie Mellon University. He is active in the pharmacy community and is a member of several industry associations.
Prior to this role, Mr. Rizzo served in many key roles at Inovalon since his joining the Company in 2002, and most recently as Chief Innovation Officer for Inovalon until 2016. In this role, Mr. Rizzo was responsible for the coordination and oversight of all product development and material product updates and expansions of capability; including design, functionality, development, quality testing processes, and modularized rollouts and operational expansions. Mr. Rizzo was also responsible for all aspects of the Company’s dataset assets, including processes to support and achieve the high integrity, reliability, and security; accuracy and efficiency of integration; comprehensive policies and procedures for the access and utilization; and ultimate realization of value for the Company, clients, and the healthcare community. In addition to these roles, Mr. Rizzo served as the Company’s Security Officer and served in a number of key roles at Inovalon, including the Company’s Chief Product Officer, and was responsible for all major product roll outs since the Company first started major operations.
Prior to joining Inovalon, Mr. Rizzo served as Vice President of Product Development for Founding Advisors, Inc., a specialized management consulting firm. In the service of Founding Advisors, Mr. Rizzo served in various product development roles on behalf of Founding Medical Informatics, Inc. and the Medical Reliance Group, LLC, including leading the technology and software design and development of the core products of Medical Site Reviewers.
Prior to joining Founding Advisors, Mr. Rizzo was a senior consultant at Arthur Andersen, LLP, where he advised clients in the healthcare, telecommunications, and insurance industries. In his capacity as lead analyst, Mr. Rizzo performed in-depth data analysis and financial investigations of health and life insurance companies in order to evaluate appropriate recapture of reinsurance receivables and government coverage for customers of life insurance companies in liquidation. While at the firm, he also performed in-depth industry financial investigations in support of clients’ strategic expansion and investment decisions.
In addition to his Fellow role at Inovalon, Mr. Rizzo serves as a trustee at Loyola University Maryland, where he graduated Summa Cum Laude with a Bachelor of Arts degree in Business Administration, and is highly active in a number of philanthropic organizations serving disadvantages communities in Maryland. Additionally, Mr. Rizzo holds the Chartered Financial Analyst designation and is active within the entrepreneurial, venture capital, and private equity community throughout the mid-Atlantic region.
Prior to this role, Mr. Wychulis was the president and member of the Executive Leadership Team of Inovalon, where he was responsible for the oversight of the Company’s day-to-day operations across its business units and the related industry insight support, client engagement, and strategic relationships. Prior to joining Inovalon in 2014, Mr. Wychulis served as the President of the WellPoint New York government program health plan, HealthPlus, an Amerigroup company, where he was responsible for the full P&L management of the company’s $1.9 billion product portfolio within the New York region. Mr. Wychulis was responsible for oversight of medical management, quality improvement, finance, compliance, human resources, government relations, provider contracting, marketing, enrollment, strategic planning, and the managed long-term care product. Mr. Wychulis played a pivotal role in working with state regulators in transforming New York’s Medicaid delivery system through the state’s Medicaid Redesign Team (MRT), worked on complex premium rate setting issues within the state, and served on the state’s quality incentive committee for the long-term care populations. Under Mr. Wychulis’ direction, the plan realized a 300-percent growth in membership and a 600-percent increase in premium revenue. In 2013, he was awarded WellPoint’s Pinnacle Award, the company’s highest management award. In the same year, HealthPlus was the most profitable of the 20 WellPoint government program plans, while maintaining an upper tier quality and outcome ranking, and achieving NCQA accreditation status for the plan.
Prior to joining WellPoint/Amerigroup, Mr. Wychulis served as President and CEO of the Florida Association of Health Plans, where he expanded the Association from 8 to 26 plans in 4 years. Mr. Wychulis was responsible for driving the successful development of public policy and legislation that resulted in a significant expansion of covered lives and an increase in hundreds of millions of dollars in additional revenue to the Florida managed care plans. He facilitated critical strategic relationships with the hospital, medical, and health advocacy community and associations. Mr. Wychulis also served as President and CEO of HealthPlan Southeast, a North Florida managed care company comprised of state employee, commercial, and Medicaid/CHP contracts. Mr. Wychulis was instrumental in improving the plan’s performance and positioning it to serve as the base for the successful acquisition and integration of multiple Florida managed care organizations that are now Coventry/Aetna Florida.
Mr. Wychulis received his Bachelor of Political Science degree from the City College of New York and his Master of Health Administration and Planning from the Wagner School of Public Administration at New York University.